P&G Health Q3 results: PAT dips 21% to Rs 46 cr, revenue at Rs 252 cr
The company, which follows the July-June financial year, reported a profit after tax (PAT) of Rs 59 core a year ago
 "P&G Health Q3 results: PAT dips 21% to Rs 46 cr, revenue at Rs 252 cr")
Procter & Gamble Health on Thursday said its profit after tax declined 21 per cent year-on-year to Rs 46 crore for the third quarter ended March 2024.
The company, which follows the July-June financial year, reported a profit after tax (PAT) of Rs 59 core a year ago.
Its revenue from operations declined to Rs 252 crore for the period under review compared to Rs 321 crore in the year-ago period, Procter & Gamble (P&G) Health said in a regulatory filing.
"The company's continued efforts to strengthen our reach and distribution with a transformed go-to-market model reflected in a one-time impact on the quarter's sales owing to the transition and optimisation of trade management and inventory," P&G Health India Managing Director Milind Thatte said.
"However, we have seen sales recover in the months of March and April," he added.